Does HCV screening of blood donors affect transmission of hepatitis G virus in dialysed patients?
Gérard
C
C
Vaira
D
D
Delwaide
J
J
Lamproye
A
A
Maggipinto
G
G
Sondag
D
D
Rorive
G
G
Belaïche
J
J
Rentier
B
B
D001530:Belgium / Q000453:epidemiology; D001782:Blood Donors; D001803:Blood Transfusion / Q000592:standards*; D015331:Cohort Studies; D015897:Comorbidity; D005069:Evaluation Studies as Topic; D018067:Flaviviridae / Q000276:immunology; D006509:Hepatitis B / Q000453:epidemiology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000150:complications / Q000175:diagnosis* / Q000453:epidemiology; D018937:Hepatitis C Antibodies / Q000097:blood; D006525:Hepatitis, Viral, Human / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007676:Kidney Failure, Chronic / Q000453:epidemiology / Q000628:therapy; D008403:Mass Screening; D015995:Prevalence; D012367:RNA, Viral / Q000097:blood*; D006435:Renal Dialysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D065227:Transfusion Reaction; D014766:Viremia / Q000175:diagnosis / Q000453:epidemiology
D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies; D012367:RNA, Viral